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Introduction
Successful development and marketing of an automated
product requires accurate identification of the needs that the
instrument can satisfy and the expression of those needs as
parameters for product design. Once these parameters are
set the manufacturer must develop a product prototype to
satisfy them. Finally, extensive field testing of the proto-
type must be carried out before making the instrument
commercially available. This is very critical, especially in
healthcare automation.
The Du Pont ’aca’ analyser
The development of the Du Pont ’aca’, a clinical analyser
that automates 42 tests on blood serum and body fluids,
illustrates the above process. The heart of the ’aca’ system is
the analytical test pack containing prepackaged reagents in
their stable form. On top of the pack is a plastic header. This
carries a binary code which enables the instrument to identify
the test being run. On the header is also imprinted the name
of the test. The plastic pack which also serves as a test
cuvette in which the chemical analysis takes place is shown in
Figure 1.
The concept of the ’aca’ is straightforward. An unmeasured
amount of serum or other body fluid is poured into a sample
cup. A patient identification card is filled out (for later
transfer by photographic imaging to the test report slip)and
put into the instrument along with the cup. The test packs,
representing the tests requested by the physician, are then
loaded into the ’aca’ behind the sample cup. After the
instrument is activated the first result appears in seven
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Figure 1.
minutes and thereafter every 37 74 seconds. The test report
appears with the initial information recorded on the patient
and a digital print of the results of the tests processed on that
particular patient. The system design is shown in Figure 2.
User requirements
In developing the design parameters for the ’aca’ Du Pont
based its decisions on user requirements; this paper will use
as an example those of STAT or emergency testing which is
the most demanding application of automation. These
requirements were ranked in priority order as assessed by the
development team after extensive discussions with clinical
laboratory personnel.
(1) Quick turn-round time. STAT testing demands quick
results. The plan therefore was to develop a system that
would provide the first test results in less than eight minutes
and successive test results every 37 to 74 seconds.
(2) Round-the-clock availability. The second requirement in
STAT testing is that the automated system be available 24
hours a day, 7 days a week. The design parameter was that
the ’aca’ always be on standby when not in use with no
start-up or shut-down time required before analyses can
be commenced.
(3) Minimum staffing. It is difficult to have skilled technol-
ogists available at all times, particularly at night and weekends.
Therefore, the third user requirement is for a system that is
relatively easy to use. The matching design parameter of the
’aca’ was simplicity of operation with minimum operator
involvement.
(4) Accuracy and precision. Because STAT tests are often
the most critical tests the fourth user requirement is a high
degree of accuracy and precision. The design parameter set
was that a coeficient of variation equal to or less than 5
percent on enzyme tests and equal to or less than 3 percent
on chemical tests should be obtained in routine use. Du Pont
also provides the use of reference methodology in chemistry
procedure development.
Figure 2.
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(5) Compatibility with routine procedures. Another STAT
requirement is that the test results should be compatible
with routine procedures. Often hospitals, particularly medium
and large ones, have several clinical analysers one of which
may run the bulk of routine chemistries during the day. In
this situation the ’aca’ often complements the other analyser
by running the STAT and speciality tests during the days,
nights and weekends. It is very important that physicians see
only one set of normal ranges in order to reduce excessive
interpretation. Thus, the ’aca’ design parameter was that the
slope and the intercept should be adjustable. The user
laboratory can then run split sample comparison studies and
develop one set of normal ranges for those tests that are run
on more than one system.
(6) Positive patient identification. The sixth critical require-
ment is positive patient identification; no mistaking of the
patient sample and test result must be possible. The corres-
ponding design parameter for the ’aca’ was photographic
transfer of patient information to the test report sheet.
(7) Variety of tests. The seventh market requirement is
for a variety of automated tests. The ’aca’ was introduced in
1971 with eight automated tests. Currently the ’aca’ performs
42. Virtually all tests that are carried out in the STAT mode
in the clinical chemistry area have been automated on the
’aca’. In addition, one or more tests may be requested on a
particular patient by the physician, so the system must
operate in a discrete mode with zero changeover time between
the different test procedures.
Identifying these priorities is an important product devel-
opment process. The manufacturer identifies the requirements
of the marketplace, sets priorities for these, and then develops
design criteria so that the product will fit the designated
applications.
Field evaluations
Once a manufacturer develops the product prototype, the
next stage is to test it in the field. It is important that
extensive field evaluations be conducted by capable and
demanding potential users prior to marketing.
In the case of the ’aca’, three major field evaluations
were conducted in the USA the, University of Wisconsin
Medical Center, the Upstate Medical Center in Syracuse,
New York, and the University of Alabama Medical Center.
As a result of these evaluations, a monograph was published
and widely distributed by those involved in the field evaluat-
ion at the University of Alabama Ill. A paper by the
evaluators at the Upstate Medical Centre in Syracuse was
published [2]. Therefore, the information from the evaluat-
ions was widely disseminated for study by clinical laboratory
personnel.
Although field evaluation is very expensive and time
consuming, it is vital. It is absolutely imperative that the
manufacturer does these evaulations so that the buyer of
the equipment does not have to. The advantage from the
buyer’s standpoint is that the system has been thoroughly
evaluated, so it can be rapidly put into routine clinical
use.
Field evaluation is also critical from the standpoint of
the manufacturer. Earlier users will provide a satisfied
referral base which is a major factor in the success of a new
product.
Requirements upon marketing
Once the product has been launched commercially, the
manufacturer must address a different set of requirements
and spend considerable resources to satisfy them. In clinical
laboratory automation, the first of these needs is service.
Using the Du Pont ’aca’ as an example, the most stringent
service requirements that apply to STAT market service were
matched against the programme parameters of manufacture;
these are discussed below.
(1) Instrument reliability. The first service requirement is
for minimum downtime, which means a manufacturer must
place a high priority on instrument reliability. Du Pont
studies show that the ’aca’ system is operative about 98
percent of the time. Du Pont also has a retrofitting pro-
gramme for the ’aca’. Developments in the design of the ’aca’
that improve reliability are retrofitted to all instruments in
the field. By continuously improving the instrument’s
reliability, the downtime is further minimised.
(2) Round-the-clock servicing. In addition, a very extensive
and expensive servicing programme ensures minimum down-
time in STAT testing automation. Because the ’aca’ system
operates 24 hours a day, 7 days a week, around-the-clock
service is required. This is handled through a large network of
satellite service engineers, backed up by regional and area
service centres.
(3) Modular components. The ’aca’ system design is modular
so that parts can be easily replaced. The service representative
doesn’t have to fix the part on site but, rather, can inter-
change the necessary part to get the system back in operation
quickly. To ensure that parts are available when needed, Du
Pont has set up regional parts depots at several major airports.
Once a service engineer has contacted a laboratory, identified
the problem and isolated it to one component, a call to the
regional parts depot will have the necessary component on
the next plane, thus ensuring minimum downtime.
(4) Telephone trouble-shooting. Telephone trouble-shooting
is another very important aspect of Du Pont’s total service
programme. Every new user attends an ’aca’ training session.
With this background and the use of the operator’s manual,
trouble-shooting solves 9 out of every 10 problems over the
phone, taking far less time than calling in a service engineer.
(5) Preventive maintenance. Du Pont schedules annually a
programme of preventive maintenance calls for each location.
Service representatives check out the system thoroughly and
replace any defective or potentially defective components.
At that time, any additional improvements developed since
the last visit are retrofitted to the ’aca’.
Training programme
Another support requirement once marketing is achieved is
training. One reason is that clinical laboratories have high
personnel turnover. In addition, a large number of medical
technologists operate the system; not only during the day-
time but at night and on weekends. Du Pont, therefore,
trains thousands of people a year to operate the ’aca’.
This is accomplished through a comprehensive training
programme. First, Du Pont has training centres throughout
the world where systems are in routine clinical use:
Wilmington, Delaware; Geneva, Switzerland; Claremont,
California and Tokyo, Japan. There is a basic course, and an
advanced one for those who have gone through initial train-
ing and operated the system.
Du Pont also has an audio-visual instruction series, that
laboratories can use in-house. Also, Du Pont technical
representatives and service engineers conduct user conferences
with customers to discuss many aspects of the instrument
and its use, for example calibration, quality control and
trouble-shooting. A Du Pont technical representative also
may go into a laboratory and carry out training on a one-
on-one basis to develop personnel for required levels of
expertise.
Very important to the training programme are readable
manuals. The ’aca’ manuals have been tested and are easy
to follow; they are used as part of the training process and to
answer questions. There is little likelihood they simply sit on
the shelf.
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Staying up to date
Another area that is extremely important in developing a
commercial product is the manufacturer’s obligation to
maintain the state-of-the-art technology for the user. This
is especially critical in clinical laboratory automation, which
is a fast-changing, high-technology area.
In the ’aca’, this philosophy governs the technical advances
in both the instrumentation and test chemistries. In 1971,
the ’aca’ was introduced with a 30-channel capacity. Eight
automated tests were available. Today a number of models
and 42 tests are available. The ’aca’ II has 60 channels, which
can automate up to 60 tests. The ’aca’ III is a microprocessor-
controlled system with virtually unlimited test capabilities.
Many ’aca’ users have upgraded their systems. Du Pont has
attempted to make this upgrading as easy as possible by
providing accessories that can be retrofitted onto the system.
Whenever a new model or accessory is introduced, Du Pont
takes steps to make it easy for existing users to increase
systems capability. Therefore, a laboratory can, if it so
elects, continue to use the same system it purchased initially
but with the increased capability similar to the latest systems
available to new users.
In some cases, it is not technically feasible to upgrade or
retrofit a system; for example, going from an ’aca’ or an
’aca’ II, which have solid state computer systems, to an
’aca’ III, which is microprocessor controlled. In these cases,
Du Pont offers an exchange programme which allows a
fairly substantial trade-in value to minimise the cost of up-
grading to existing ’aca’ users.
In the chemistry area, Du Pont offers all new tests to
every user.
A manufacturer also is responsible for providing various
financial options for the customer because capital in the
clinical laboratory is limited. In addition to purchase, Du
Pont provides several leasing options and an instrument
rental and a fee-per-test programme to fit customers’ varying
financial situations.
Professional and ethical responsibilities
Manufacturers in the healthcare field also have other respons-
ibilities.
One that Du Pont feels is particularly important is transfer
and sharing of expertise. An example of this in the clinical
laboratory is management training. Du Pont has seen this
need develop for a number of years. It is not unusual for
clinical laboratory technical personnel to move up to manage-
ment training. Du Pont has developed a programme called
"Insight", an eight-hour course on financial management in
the clinical laboratory.
Supporting professional societies is another responsibility
of manufacturers in the healthcare field. This support can be
in terms of providing communications, legal or technical
skills and monetary or human resources. For example, Du
Pont personnel are actively involved in The US National
Clinical Laboratories Standards Committee.
And lastly, the manufacturer in the clinical laboratory
should provide ethical assistance in making an automation
decision. Essentially, this is a process which gives key
decision-makers information for judging whether or not auto-
mation will be of use to them.
For the ’aca’, Du Pont conducts value-in-use analyses to
determine the economic viability and cost effectiveness of
the system, given the specific requirements of the individual
clinical laboratory.
Conclusion
In summary, a manufacturer of analytical instruments must
first identify the requirements in the clinical laboratory and
then develop the product that mets them. Second, the
manufacturer must conduct extensive field evaluations of
the product prior to marketing to ensure that the first
purchasers can rapidly incorporate the product into routine
clinical use.
Third, once a commercial instrument is available, the
manufacturer must commit large resources to service, train-
ing and maintaining the state-of-the-art tchnology. Finally,
the manufacturer must provide accurate representation and
contributions to professional healthcare societies.
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